Postoperative Adjuvant TACE Treatment in CK18 Positive Patients
NCT02724345 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 320
Last updated 2016-03-31
Summary
To evaluate and analyse the clinical effect and application value of postoperative adjuvant TACE treatment in patients with different expression levels of CK18 using randomized controlled study and provide evidence for the necessity of postoperative adjuvant TACE.
Conditions
- Postoperative Adjuvant TACE
- Hepatocellular Carcinoma.
Sponsors & Collaborators
-
Eastern Hepatobiliary Surgery Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-01-31
- Primary Completion
- 2015-06-30
- Completion
- 2015-12-31
Countries
- China
Study Locations
More Related Trials
-
Efficacy of Sequential TACE and PVE on the Resectability of Hepatitis B Related HCC
NCT00834158 ·Status: COMPLETED ·Phase: NA
-
Combined Chemoembolization and Systemic Hyperthermia for Unresectable Hepatocellular Carcinoma
NCT01817205 ·Status: TERMINATED ·Phase: NA
-
RCT on Adjuvant TACE After Hepatectomy for HCC
NCT01512407 ·Status: COMPLETED ·Phase: NA
-
Prospective Collection of Therapeutic Efficacy and Safety Data in Patients with Unresectable Hepatocellular Carcinoma
NCT06788353 ·Status: RECRUITING
-
Postoperative Adjuvant Therapy of HCC Based on PD-1
NCT05307926 ·Status: COMPLETED
-
Efficacy Study of TACE to Treat Hepatocellular Carcinoma After Operation
NCT02631499 ·Status: UNKNOWN ·Phase: PHASE4
-
Adjuvant Therapies for Patients With HCC and MVI
NCT02436902 ·Status: UNKNOWN ·Phase: PHASE3
-
TACE as an Adjuvant Therapy After Radiofrequency Ablation (RFA) for Hepatocellular Carcinoma
NCT00556803 ·Status: UNKNOWN ·Phase: PHASE4
-
Prognostic Impact of Adjuvant Therapy in Primary Hepatic Sarcomatoid Carcinoma
NCT06950814 ·Status: RECRUITING
-
Adjuvant TACE to Reduce the HCC Recurrence After Resection
NCT02788526 ·Status: COMPLETED ·Phase: PHASE3
-
Different Regimens of Transarterial Chemoembolization for Hepatocellular Carcinoma
NCT00493402 ·Status: COMPLETED ·Phase: PHASE3
-
TACE/HAIC Combined With Lenvatinib and Sintilimab in Neoadjuvant Therapy for Intermediate-stage HCC
NCT05250843 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma
NCT00827554 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy of Postoperative Adjuvant Treatments for Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis
NCT01033578 ·Status: UNKNOWN ·Phase: NA
-
Radiofrequency-assisted Liver Resection in Intractable Liver Cancer
NCT04413526 ·Status: COMPLETED
-
Cytoreductive Surgery and Transarterial Chemoembolization (TACE) Versus TACE for Hepatocellular Carcinoma
NCT00820157 ·Status: COMPLETED ·Phase: NA
-
Comparison of Treatment of Recurrent HCC With Repeat Hepatectomy,and TACE With AFP Conversion
NCT02728219 ·Status: COMPLETED ·Phase: NA
-
TACE as an Adjuvant Therapy After Hepatectomy for HCC
NCT01966133 ·Status: UNKNOWN ·Phase: PHASE3
-
Adjuvant Anti-Recurrence Treatment With Rapamycin on Early-stage HCC
NCT02724332 ·Status: COMPLETED ·Phase: PHASE1
-
TACE Plus Multikinase Inhibitor and I-125 Seeds Brachytherapy for HCC With Branch PVTT
NCT04967495 ·Status: UNKNOWN ·Phase: NA
-
Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients
NCT00849264 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Hepatocellular Carcinoma With Radiofrequency Ablation (RFA) Associated With Postoperative TACE
NCT00730860 ·Status: UNKNOWN ·Phase: NA
-
Adjuvant Radiotherapy Comparing TACE for Curative HCC
NCT02125396 ·Status: UNKNOWN ·Phase: PHASE3
-
Hepatectomy Versus Radiofrequency Ablation for Hepatocellular Carcinoma Adjacent to Major Blood Vessels
NCT00814242 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Neo-TACE-HAIC for PVTT-HCC
NCT04181931 ·Status: UNKNOWN ·Phase: NA